Gamida Cell Ltd
Change company Symbol lookup
Select an option...
GMDA Gamida Cell Ltd
TATT TAT Technologies Ltd
DARE Dare Bioscience Inc
REXR-C Rexford Industrial Realty Inc
AQNA Algonquin Power & Utilities Corp
NAOV Nanovibronix Inc
IOT Samsara Inc
GSIT GSI Technology Inc
GME GameStop Corp
CMBM Cambium Networks Corp
Go

Health Care : Biotechnology | Small Cap Value
Based in Israel
Company profile

Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and potency. The following are the Company's clinical pipeline products: Omidubicel dedicated to hematologic malignancies and severe aplastic anemia; GDA-201 dedicated for treatment of non-Hodgkin Lymphoma; GDA-301, GDA-401, GDA-501 dedicated to treatment of solid tumors, GDA-601 dedicated to multiple myeloma.

Postmarket

Last Trade
Delayed
$2.37
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.37
Day's Change
0.21 (9.72%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.43
Day's Low
2.15
Volume
(Heavy Day)
Volume:
3,387,478

10-day average volume:
2,122,717
3,387,478
  • Prev Close
    2.16
  • Today's Open
    2.20
  • Day's Range
    2.15-2.43
  • Avg Vol (10-day)
    2.1M
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    40
  • 52-Wk Range
    0.56 - 3.66
    LowHigh
  • (08/11/22 - 03/27/23)
    35.25%
  • 118.2%
  • Market Cap
    250.2M
  • Shares Outstanding
    105.6M
  • -1.18
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 30.53
  • (% of float 05/15/23)
    5.92

Latest News

May 31, 2023
4:30 pm ET
BusinessWire
7:00 am ET
BusinessWire
May 22, 2023
8:01 am ET
BusinessWire
May 16, 2023
8:15 am ET
MarketWatch
May 15, 2023
4:05 pm ET
BusinessWire
May 11, 2023
5:20 pm ET
BusinessWire
April 20, 2023
11:46 am ET
PR Newswire
April 19, 2023
8:15 am ET
BusinessWire
April 18, 2023
7:16 pm ET
BusinessWire
April 17, 2023
4:16 pm ET
BusinessWire
March 27, 2023
7:00 am ET
BusinessWire
March 20, 2023
4:30 pm ET
BusinessWire
8:00 am ET
BusinessWire
March 07, 2023
8:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.